Deep-Breathing device may shield lung cancer patients from radiation side effects

NCT ID NCT06688422

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether using an incentive spirometer—a device that encourages deep breathing—can lower the risk of lung inflammation (pneumonitis) in people with advanced lung cancer receiving chemotherapy and radiation. About 100 participants will use the device 10 times every hour while awake during treatment and for three months after. Researchers will track lung inflammation, survival, and quality of life over one year.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOTHERAPY-INDUCED PNEUMONITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • MD Anderson Cancer Center at Cooper

    RECRUITING

    Camden, New Jersey, 08103, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.